Optimizing HIV retesting during pregnancy and postpartum in four countries: a cost‐effectiveness analysis
Authors:
- Julianne MeisnerJMJulianne Meisner
- D Allen RobertsDRD Allen Roberts
- Patricia RodriguezPRPatricia Rodriguez
- Monisha SharmaMSMonisha Sharma
- Morkor Newman OwireduMOMorkor Newman Owiredu
- Bertha GomezBGBertha Gomez
- Maeve B de MelloMMMaeve B de Mello
- Alexey BobrikABAlexey Bobrik
- Arkadii VodianykAVArkadii Vodianyk
- Andrew StoreyASAndrew Storey
- George GithukaGGGeorge Githuka
- Thato ChidarikireTCThato Chidarikire
Open Access
- 31 March 2021
- journal article
- research article
- Published by Wiley in Journal of the International AIDS Society
- Vol. 24 (4) , e25686
Abstract
Introduction: HIV retesting during late pregnancy and breastfeeding can help detect new maternal infections and prevent mother‐to‐child HIV transmission (MTCT), but the optimal timing and cost‐effectiveness of maternal retesting remain uncertain.Methods: We constructed deterministic models to assess the health and economic impact of maternal HIV retesting on a hypothetical population of pregnant women, following initial testing in pregnancy, on MTCT in four countries: South Africa and Kenya (high/intermediate HIV prevalence), and Colombia and Ukraine (low HIV prevalence). We evaluated six scenarios with varying retesting frequencies from late in antenatal care (ANC) through nine months postpartum. We compared strategies using incremental cost‐effectiveness ratios (ICERs) over a 20‐year time horizon using country‐specific thresholds.Results: We found maternal retesting once in late ANC with catch‐up testing through six weeks postpartum was cost‐effective in Kenya (ICER = $166 per DALY averted) and South Africa (ICER=$289 per DALY averted). This strategy prevented 19% (Kenya) and 12% (South Africa) of infant HIV infections. Adding one or two additional retests postpartum provided smaller benefits (1 to 2 percentage point increase in infections averted versus one retest). Adding three retests during the postpartum period averted additional infections (1 to 3 percentage point increase in infections averted versus one retest) but ICERs ($7639 and in Kenya and $11 985 in South Africa) greatly exceeded the cost‐effectiveness thresholds. In Colombia and Ukraine, all retesting strategies exceeded the cost‐effectiveness threshold and prevented few infant infections (up to 31 and 5 infections, respectively).Conclusions: In high HIV burden settings with MTCT rates similar to those seen in Kenya and South Africa, HIV retesting once in late ANC, with subsequent intervention, is the most cost‐effective strategy for preventing infant HIV infections. In these settings, two HIV retests postpartum marginally reduced MTCT and were less costly than adding three retests. Retesting in low‐burden settings with MTCT rates similar to Colombia and Ukraine was not cost‐effective at any time point due to very low HIV prevalence and limited breastfeeding.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (P30‐AI027757, K01 AI116298, K01 MH115789)
- Bill and Melinda Gates Foundation (OPP1177903)
- United States Agency for International Development (GHA‐G‐00‐09‐00003)
- World Health Organization (018/CDS/HIV/004, 201742717, 2018/865307‐0)
- National Institute of Environmental Health Sciences (T32 ES015459‐09)
This publication has 40 references indexed in Scilit:
- Using Mobile Phones and Short Message Service to Deliver Self‐Management Interventions for Chronic Conditions: A Meta‐ReviewWorldviews on Evidence-Based Nursing, 2014
- Incident HIV during Pregnancy and Postpartum and Risk of Mother-to-Child HIV Transmission: A Systematic Review and Meta-AnalysisPLOS Medicine, 2014
- Effectiveness and Cost Effectiveness of Oral Pre-Exposure Prophylaxis in a Portfolio of Prevention Programs for Injection Drug Users in Mixed HIV EpidemicsPLOS ONE, 2014
- Antiretroviral therapy uptake and coverage in four HIV community cohort studies in sub‐Saharan AfricaTropical Medicine & International Health, 2012
- The Contribution of Maternal HIV Seroconversion During Late Pregnancy and Breastfeeding to Mother-to-Child Transmission of HIVJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- In utero and intra-partum HIV-1 transmission and acute HIV-1 infection during pregnancy: using the BED capture enzyme-immunoassay as a surrogate marker for acute infectionInternational Journal of Epidemiology, 2011
- Antenatal HIV-1 RNA load and timing of mother to child transmission; a nested case-control study in a resource poor settingVirology Journal, 2010
- A Case Series of 104 Women Infected with HIV‐1 via Blood Transfusion Postnatally: High Rate of HIV‐1 Transmission to Infants through Breast‐FeedingThe Journal of Infectious Diseases, 2009
- Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort studyThe Lancet, 2007
- Cost-Effectiveness of HIV Rescreening During Late Pregnancy to Prevent Mother-to-Child HIV Transmission in South Africa and Other Resource-Limited SettingsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006